04:15 AM EDT, 05/22/2024 (MT Newswires) -- Dyne Therapeutics ( DYN ) said late Tuesday it priced an underwritten public offering of 10.5 million common shares at $31 per share for expected gross proceeds of $325.5 million.
The company granted the underwriters a 30-day option to buy up to an additional 1.6 million shares.
The offering is expected to close on or about Friday.
Price: 32.95, Change: +0.32, Percent Change: +0.98